Biography

Lin has extensive experience in prosecuting patents in several technical areas including biotechnology, pharmaceuticals, chemistry, and advanced materials.

Lin's additional focuses include medical diagnostics, immunotherapeutics, drug formulation and delivery, nanotechnology, microfluidics, microscopy, chromatography, and industrial chemical and biochemical processes. Lin also provides opinions, litigation support, and patent strategic advice, and is experienced in patent due diligence and post-grant proceedings. Lin's practice focuses on providing efficient and insightful patent drafting and prosecution for universities, early-stage companies, and large corporations internationally.

Prior to practicing law, Lin had an academic research career in the U.S., Germany, and Austria, taught biophysics, physiology, and pharmacology, and was a grant review administrator at the National Institutes of Health. As a patent lawyer, Lin has more than 20 years of experience working at law firms in the Boston and Washington, D.C. areas, as well as serving as an in-house patent attorney at a major biotechnology company.

Lin plays classical guitar and is a member of the Boston Classical Guitar Society. He also enjoys listening to music, hiking, and traveling.

Services/Industries

Education

  • Georgetown University Law Center  (J.D.)
  • Vanderbilt University  (Ph.D.)
  • Tulane University  (B.S., summa cum laude)

Bar Admissions

  • Massachusetts
  • Maryland

Court and Other Admissions

  • U.S. Patent and Trademark Office

Firm Highlights

Event

IP & Business Transactional Strategies as Life Science Companies Plan Their U.S. Market Entry

Business law attorney Eugene Ho and IP attorney Beverly Hjorth will be presenting for ACTION Innovation Network members for its webinar series, discussing what life science companies should be thinking about when considering entry...

Publication/Podcast

EU-U.S. Privacy Shield Invalidated: Does Your Company Have a Plan B?

On Thursday, July 16, 2020, the Court of Justice of the European Union (“CJEU”) invalidated the EU-U.S. Privacy Shield (“Privacy Shield”) in Data Protection Commissioner v. Facebook Ireland and Maximillian Schrems (Case C-311/18...

News

Verrill’s Wide-Ranging Private Wealth Law Practice Recognized in 2020 Chambers and Partners High Net Worth Guide

(July 20, 2020) – Verrill attorneys Michael Fay, Kurt Klebe, Mary McQuillen, and Jacqueline Rider were recognized in the Chambers High Net Worth 2020 Guide , Chambers and Partners' fifth edition of the publication...

Publication/Podcast

PPP: How is Maine Faring?

Originally enacted on March 27, the Paycheck Protection Program (PPP) offers loan support and (potentially) loan forgiveness to qualifying small businesses – generally defined as those with not more than 500 employees. According to...

News

After the EPA Inspector Leaves

On July 17, environmental attorney Mat Todaro appeared on an episode of Amplify Your Process Safety, a process safety and risk management podcast. Co-host Rob Bartlett and Mat discuss EPA inspections, what to expect...

Event

2020 OHRP Exploratory Workshop

Health care attorney Emily Fogler will be presenting at the 2020 OHRP Exploratory Workshop in the third session, discussing sharing responsibilities and protecting participants - redefining roles in the single IRB era. For more...

Blog

Verrill Helps State’s Largest Solar Project Obtain Principal Environmental Permit

Blog

Verrill Helps State’s Largest Solar Project Obtain Principal Environmental Permit

Matter

2017 Emera Distribution Rate Case

Verrill represented Emera in its 2017 distribution rate case before the Maine PUC, which included: defeating Staff's proposed reduction to allowed return on equity for "management inefficiency;" approval of new expenditures, such as an...

Matter

Management Audit

Verrill represented Emera in its 2016 distribution rate case before the Maine PUC. The case involved issues relating to significant new capital investments, including Emera's new customer information system and a controversial substation investment...